Comparison of Omalizumab Treatment Response in Patients with Chronic Spontaneous Urticaria and Symptomatic Dermographism: A Single-Center Retrospective Study.

International archives of allergy and immunology(2023)

引用 1|浏览5
暂无评分
摘要
Omalizumab treatment improved disease control and quality of life in patients with SDerm. The findings of this study should be supported by randomized placebo-controlled studies.
更多
查看译文
关键词
Anti-IgE,Omalizumab,Quality of life,Treatment efficacy,Urticaria
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要